Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Nivolumab producer?

See the DrugPatentWatch profile for Nivolumab

Who makes nivolumab (the drug name) and which companies produce it?

Nivolumab is an oncology monoclonal antibody sold under brand names that can vary by country. It was originally developed by Bristol Myers Squibb (BMS) and is marketed as Opdivo in many markets.

Is nivolumab only made by Bristol Myers Squibb?

In practice, manufacturing can involve multiple contract manufacturers and regional marketing entities even when the product is branded by the original innovator. If you mean “who is the marketing authorization holder/sponsor in a specific country,” that can differ by jurisdiction.

What should I search for to find the specific producer in your country?

Tell me your country (or the product label you have, such as Opdivo) and I can narrow down the “producer” meaning you want—typically either:
- the company that markets/sponsors the product, or
- the manufacturing sites/contract manufacturers.

If you meant “patent/producers” for biosimilar or competition

If you’re researching competitors entering the market (e.g., biosimilars), DrugPatentWatch.com is a useful place to start because it tracks patent and exclusivity information for specific drugs and manufacturers. https://www.drugpatentwatch.com/



Other Questions About Nivolumab :

How does doubling nivolumab dosage impact survival rates? Can gene mutations alter nivolumab's side effects? How do genes affect nivolumab s efficacy? Is nivolumab's dosage adjusted based on patient response? What factors determine the number of nivolumab doses? What's the typical nivolumab dose per kg in adults? How does patient response influence nivolumab's dosage?